(Q46884990)

26 December 2017

title

Population pharmacokinetics of intravenous busulfan in patients undergoing hematopoietic stem cell transplantation (English)

1 reference

26 December 2017

1 reference

Takama H

1

1 reference

26 December 2017

Tanaka H

2

1 reference

26 December 2017

Nakashima D

3

1 reference

26 December 2017

Ueda R

4

1 reference

26 December 2017

Takaue Y

5

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

Bone Marrow Transplantation

published in

1 reference

26 December 2017

volume

37

1 reference

26 December 2017

issue

4

1 reference

26 December 2017

page(s)

345-351

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1705252

exact match

0 references

cites work

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Pharmacokinetics of high-dose busulphan in relation to age and chronopharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

A phase I/II study of multiple-dose intravenous busulfan as myeloablation prior to stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation: a phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Stability and performance of a population pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Bootstrap Methods: Another Look at the Jackknife

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

The importance of modeling interoccasion variability in population pharmacokinetic analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Population pharmacokinetic analysis resulting in a tool for dose individualization of busulphan in bone marrow transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Population pharmacokinetics of oral busulfan in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

A simple approximation for busulfan dose adjustment in adult patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease: defining a therapeutic window for i.v. BuCy2 in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Intravenous busulfan in pretransplant chemotherapy: bioavailability and patient benefit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

Pharmacokinetics of busulfan: correlation with veno-occlusive disease in patients undergoing bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

7 January 2021

Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

7 January 2021

Gas chromatographic-mass spectrometric assay for busulfan in biological fluids using a deuterated internal standard

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

7 January 2021

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

7 January 2021

Practical experience and issues in designing and performing population pharmacokinetic/pharmacodynamic studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705252

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705252

1 reference

26 December 2017

1 reference

26 December 2017